Literature DB >> 1497483

Teratogenicity of arotinoids (retinoids) in the rat whole embryo culture.

R Bechter1, G D Terlouw, M Tsuchiya, T Tsuchiya, A Kistler.   

Abstract

Structural modifications of the arotinoid molecule RO 13-7410 led to a difference in the teratogenic potencies of more than five orders of magnitude in mice in vivo and in micromass cultures of rat embryonic limb bud cells (Kistler et al. 1990). Five of these retinoids were selected and tested in rat whole embryo culture to determine the suitability of this in vitro test system for the identification of potentially non-teratogenic derivatives among this class of chemicals. The highest concentrations of the compounds with no effects (NOAEL) on general conceptus growth, on differentiation and on the frequency of dysmorphogenic embryos in vitro were compared with the lowest effective teratogenic doses in vivo (LOAEL) or with the concentrations leading to 50% inhibition of limb bud cell differentiation (IC50) in vitro. NOAEL's for the parameters of conceptus development ranged from 10(-5) micrograms/ml (0.03 nM) to 10 micrograms/ml (28.7 microM) for the compounds tested. These correlated very well with LOAEL and IC50 (R greater than 0.95). The types of dysmorphogenesis in vitro were those typical for retinoids, and for the most part resembled the malformations found in vivo. We conclude that the whole embryo culture system is a useful tool for the preliminary testing of retinoids.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1497483     DOI: 10.1007/bf01974014

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  15 in total

1.  Limb bud cell cultures for estimating the teratogenic potential of compounds. Validation of the test system with retinoids.

Authors:  A Kistler
Journal:  Arch Toxicol       Date:  1987-08       Impact factor: 5.153

2.  Postimplantation embryo culture for the assessment of the teratogenic potential and potency of compounds.

Authors:  L Cicurel; B P Schmid
Journal:  Experientia       Date:  1988-10-15

3.  Teratogenic activity of retinoic acid.

Authors:  D M Kochhar
Journal:  Acta Pathol Microbiol Scand       Date:  1967

4.  All-trans retinoic acid and 13-cis-retinoic acid in the rat whole-embryo culture: abnormal development due to the all-trans isomer.

Authors:  S Klug; C Lewandowski; L Wildi; D Neubert
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

5.  Morphological differences elicited by two weak acids, retinoic and valproic, in rat embryos grown in vitro.

Authors:  R E Seegmiller; C Harris; D L Luchtel; M R Juchau
Journal:  Teratology       Date:  1991-02

6.  In vitro embryotoxicity and teratogenic potential of etretinate and etretin.

Authors:  R Bechter; L Hall
Journal:  Toxicol In Vitro       Date:  1987       Impact factor: 3.500

7.  Teratogenesis of retinoic acid in rats: susceptible stages and suppression of retinoic acid-induced limb malformations by cycloheximide.

Authors:  A Kistler
Journal:  Teratology       Date:  1981-02

8.  Retinoic acid embryopathy.

Authors:  E J Lammer; D T Chen; R M Hoar; N D Agnish; P J Benke; J T Braun; C J Curry; P M Fernhoff; A W Grix; I T Lott
Journal:  N Engl J Med       Date:  1985-10-03       Impact factor: 91.245

9.  Isotretinoin teratogenicity in mouse whole embryo culture.

Authors:  E H Goulding; R M Pratt
Journal:  J Craniofac Genet Dev Biol       Date:  1986

10.  Quantitation of rat embryonic development in vitro: a morphological scoring system.

Authors:  N A Brown; S Fabro
Journal:  Teratology       Date:  1981-08
View more
  1 in total

Review 1.  Reproduction and development.

Authors:  H Spielmann
Journal:  Environ Health Perspect       Date:  1998-04       Impact factor: 9.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.